Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in ARDX — Ardelyx, Inc.

CIK 1167557 Greenwich, CT
Back to ARDX Full portfolio

Position in ARDX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$11,812,719
-$2,799,581 QoQ
Shares Held
2,316,220
-5.1% QoQ
Ownership
0.930%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 250 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in ARDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. ARDX ranks #47 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 1,126,080 $702,155,918
2 INCY
Incyte Corp
 5,320,901 $603,177,333
3 EXEL
Exelixis, Inc.
 11,023,943 $599,812,735
4 JAZZ
Jazz Pharmaceuticals plc
 1,522,568 $366,893,205
5 BMRN
Biomarin Pharmaceutical Inc
 5,699,541 $326,127,732
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 616,170 $306,070,117
7 RVMD
Revolution Medicines, Inc.
 1,295,450 $242,611,869
8 RPRX
Royalty Pharma plc
 4,305,412 $241,404,446

All Filings in ARDX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,812,719 2,316,220
2026-03-31 $14,612,300 2,439,450
2025-12-31 $11,806,232 2,025,083
2025-09-30 $11,814,121 2,144,124
2025-06-30 $9,064,461 2,312,363
2025-03-31 $7,723,736 1,573,063
2024-12-31 $2,764,411 545,249
2024-09-30 $4,262,007 618,579
2024-06-30 $3,085,175 416,353
2024-03-31 $1,237,598 169,534
2023-12-31 $547,571 88,318
2023-09-30 $252,580 61,907
2023-06-30 $231,781 68,372
2022-06-30 $11,873 20,125
2020-12-31 $280,034 43,282
2020-09-30 $899,708 171,373
2020-06-30 $1,706,645 246,625
2020-03-31 $1,374,195 241,723